fda warning compounded semaglutide october 2025 Bad news: You may get cut off from your GLP-1 this weekβ¦ π¨ FDA Moves to Permanently
Description
The first GLP-1 RAs is exenatide, which was approved by the FDA for the treatment of T2DM in 2005
GLP-1 (glucagon-like peptide-1) is a hormone that naturally occurs in the body and helps regulate blood sugar levels by stimulating insulin secretion and inhibiting glucagon release
Once opened (punctured), store in the refrigerator and use within the beyond-use date assigned by Genesis Compounding
Semaglutide is one type of GLP-1 receptor agonist commonly used for medical weight loss
In adults with type 2 diabetes, the higher doses produced strong weight loss alongside HbA1c reductions of up to ~2.4% versus placebo [3]
